தரநிலை ஆஃப் பராமரிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தரநிலை ஆஃப் பராமரிப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தரநிலை ஆஃப் பராமரிப்பு Today - Breaking & Trending Today

(IFRX) - InflaRx's Vilobelimab Hits Primary Endpoint Goal In Late-Stage ANCA-Associated Vasculitis Study

InflaRx NV (NASDAQ: IFRX) has announced topline results from its U.S. Phase 2 IXPLORE study evaluating vilobelimab in patients . ....

Birmingham Vasculitis Score , Standard Of Care , தரநிலை ஆஃப் பராமரிப்பு ,

Santhera Announces Completion of First 6-Month Period of Pivotal VISION-DMD Trial with Vamorolone in Duchenne Muscular Dystrophy

Santhera Announces Completion of First 6-Month Period of Pivotal VISION-DMD Trial with Vamorolone in Duchenne Muscular Dystrophy
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Duchenne Muscular Dystrophy , Vision Dmd , Reveragen Biopharma Inc , Treatment Period , Santhera Pharmaceuticals , Pivotal Study , Duchenne Muscular Dystrophy Treatment , Standard Of Care , Pivotal Trial , Side Effects , பார்வை திம்ட் , சிகிச்சை காலம் , சந்தேற மருந்துகள் , முக்கிய படிப்பு , தரநிலை ஆஃப் பராமரிப்பு , முக்கிய சோதனை , பக்க விளைவுகள் ,

Marizyme Announces the Use of DuraGraft® as the Standard-of-Care in [...]

11 gennaio 2021 11:38
Fonte: Adnkronos
#salute-e-benessere
DuraGraft is a one-time intraoperative treatment used during vascular surgery to reduce the incidence of complications associated with graft failure
JUPITER, Fla., Jan. 11, 2021 /PRNewswire/ Marizyme, Inc. (OTCQB: MRZM), a global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, today announced as of August 2020 the Vienna Heart Center North Floridsdorf of Vienna, Austria was the first clinic worldwide to use the company s flagship product, DuraGraft® as the standard-of-care for flushing and storage of the saphenous vein grafts from harvesting through grafting in Coronary Artery Bypass Grafting (CABG) patients. ....

Ingrid Mezo , Maximilian Emmert , Martin Grabwenw , Miriam Miller , Neilj Campbell , Exchange Commission , Contacts Tiberend Strategic Advisors Inc Investorsmaureen Mcenroe , Vascular Center , Vienna Heart Center North Floridsdorf , German Heart Center Berlin , Marizyme Inc , Coronary Artery Bypass Grafting , Heart Center North Floridsdorf , Assess Outcomes , Vascular Conduits , Cardiac Surgery Center , Associate Professor , Bernhard Winkler , Vienna Heart Center North , Cardiac Surgery , Chief Executive Officer , Duragraft When , Myocardial Infarction , Repeat Revascularization , Looking Statements This , Tiberend Strategic Advisors ,